The intracerebral injection of TWEAK induces MMP-9 activation, and either genetic deficiency of Fn14, or treatment with Fn14-Fc decoy inhibits cerebral ischemia-induced MMP-9 activation. The gene discussed is MMP9; the disease is brain ischemia.